ArticleClinical rheumatology2025

Leucine-rich alpha-2-glycoprotein 1 (LRG1) decrement during biologics therapy and its correlation with disease features and treatment outcomes in rheumatoid arthritis patients.

Liang Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.